Corylifol B exhibits significant anti-inflammatory activity by inhibiting key pro-inflammatory mediators such as nitric oxide (NO) and prostaglandin E2 (PGE2) in lipopolysaccharide-stimulated macrophages. This makes it a potential candidate for development in treating inflammatory diseases. It also shows moderate cytotoxic effects against certain cancer cell lines, suggesting possible use in oncology research. Additionally, due to its natural origin and structural properties, it is studied for its antioxidant capabilities, which may contribute to protective effects against oxidative stress-related conditions. Preliminary studies indicate antimicrobial effects, potentially leading to the development of anti-infective agents. It has potential applications in health products or cosmetics for reducing skin inflammation and anti-aging. Research is ongoing to explore its bioavailability and therapeutic potential in preclinical models.